Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Aug 14, 2025
Date Accepted: May 21, 2026
Date Submitted to PubMed: May 21, 2026

The final, peer-reviewed published version of this preprint can be found here:

Evaluating Postpartum Hemorrhage Transfusion Risk With a Machine Learning Model for Informed Consent: Retrospective Cohort Study

Glance J, Nielson JA, Bonnema A

Evaluating Postpartum Hemorrhage Transfusion Risk With a Machine Learning Model for Informed Consent: Retrospective Cohort Study

JMIR Form Res 2026;10:e82424

DOI: 10.2196/82424

PMID: 42166718

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Evaluating Postpartum Hemorrhage Transfusion Risk with a Machine Learning Model for Informed Consent: Retrospective Cohort Study

  • Jennifer Glance; 
  • Jeffrey Arthur Nielson; 
  • Albert Bonnema

ABSTRACT

Background:

BACKGROUND Postpartum hemorrhage requiring a blood transfusion is a concern for patients and communities. Prediction of an individual’s transfusion risk prior to delivery can be evaluated with a machine learning for shared decision making.

Objective:

OBJECTIVES To develop a machine learning model for clinical decision support use, it is proposed that internal, cleaned datasets will improve model performance over models trained with uncleaned datasets. To evaluate the role of delivery mode and indications with an individual’s postpartum transfusion risk, a machine learning model was developed for the purpose of antepartum clinical decision support and quality improvement.

Methods:

METHODS A 10-year retrospective cohort (n=12,634) was analyzed to determine the probability of transfusion based on delivery mode and delivery indications in a community-based health system. Datasets were evaluated with the best performing machine learning model. Prototype desktop clinical support applications for individual transfusion risk assessment were developed using the best performing model.

Results:

RESULTS Physician communication alone decreased the number of elective Cesarean sections compared to 10-year historical data, (p value =.02 by paired t-test, and p= <.001). The XGBoost model on the uncleaned dataset (n=1734) performance was an AUC =.71, PR-ROC =.82, and F1 score =.64). The cleaned dataset (n=1734) performance was AUC= .71, PR-ROC =.78., and F1 score= .80. A synthetic dataset derived from the cleaned dataset (n=12,000) was used for validation with an AUC =.71, PR-ROC =.79, and F1 score =. 66.

Conclusions:

CONCLUSION Machine learning models are useful to determine an individual’s postpartum transfusion risk based on delivery mode and indications for delivery. Model performance on uncleaned data was improved in this study, but did not reflect clinical decision-making for elective deliveries. Clinically relevant datasets are important for model training for use in clinical decision support tools development. Clinical Trial: N/A


 Citation

Please cite as:

Glance J, Nielson JA, Bonnema A

Evaluating Postpartum Hemorrhage Transfusion Risk With a Machine Learning Model for Informed Consent: Retrospective Cohort Study

JMIR Form Res 2026;10:e82424

DOI: 10.2196/82424

PMID: 42166718

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.